Vitamin D deficiency, autoimmunity, and graft-versus-host-disease risk: Implication for preventive therapy

Experimental Hematology

Volumn 40, Issue 4, 2012, Pages 263-267

  Benrashid, Mona ^a   Moyers, Kim ^a   Mohty, Mohamad ^b   Savani, Bipin N ^a,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITÉ DE NANTES   (France)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D;

AUTOIMMUNITY; DISEASE ASSOCIATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ANTIGEN PRESENTATION; AUTOIMMUNITY; DENDRITIC CELLS; GRAFT VS HOST DISEASE; HOSPITALIZATION; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSION; LYMPHOCYTE SUBSETS; MALNUTRITION; MODELS, IMMUNOLOGICAL; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84858342235     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.01.006     Document Type: Review

References (36)

1. Jacobsohn D.A., Arora M., Klein J.P., et al. Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease. Blood 2011, 118:4472-4479.
2. Arora M., Klein J.P., Weisdorf D.J., et al. Chronic GVHD risk score: a Center for International Blood and Marrow Transplant Research analysis. Blood 2011, 117:6714-6720.
3. Pidala J., Kurland B., Chai X., et al. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood 2011, 117:4651-4657.
4. Savani B.N., Griffith M.L., Jagasia S., Lee S.J. How I treat late effects in adults after allogeneic stem cell transplantation. Blood 2011, 117:3002-3009.
5. Flowers M.E.D., Deeg H.J. Delayed nonmalignant complications after hematopoietic cell transplantation. Thomas' Hematopoietic Cell Transplantation 2009, 1620-1637. Wiley-Blackwell, West Sussex, UK. F.R. Appelbaum, S.J. Forman, R.S. Negrin, K.G. Blume (Eds.).
6. Ferrara J.L.M., Antin J.H. The pathophysiology of graft-versus-host-disease. Thomas' Hematopoietic Cell Transplantation 2009, 208-221. Wiley-Blackwell, West Sussex, UK. F.R. Appelbaum, S.J. Forman, R.S. Negrin, K.G. Blume (Eds.).
7. Korngold R., Friedman T.M. Murine models of graft-versus-host disease and graft-versus-tumor effects. Thomas' Hematopoietic Cell Transplantation 2009, 176-187. Wiley-Blackwell, West Sussex, UK. F.R. Appelbaum, S.J. Forman, R.S. Negrin, K.G. Blume (Eds.).
8. Maruotti N., Cantatore F.P. Vitamin D and the immune system. J Rheumatol 2010, 37:491-495.
9. Palmer M.T., Lee Y.K., Maynard C.L., et al. Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem 2011, 286:997-1004.
10. Aranow C. Vitamin D and the immune system. J Invest Med 2011, 59:881-886.
11. Adorini L., Penna G. Control of autoimmune diseases by the vitamin D endocrine system. Nat Clin Pract Rheumatol 2008, 4:404-412.
12. Adorini L., Penna G., Giarratana N., et al. Dendritic cells as key targets for immunomodulation by vitamin D receptor ligands. J Steroid Biochem Mol Biol 2004, 89-90. 437-441.
13. Peelen E., Knippenberg S., Muris A.H., et al. Effects of vitamin D on the peripheral adaptive immune system: a review. Autoimmun Rev 2011, 10:733-743.
14. Kamen D.L., Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med (Berl) 2010, 88:441-450.
15. Cantorna M.T. Why do T cells express the vitamin D receptor?. Ann N Y Acad Sci 2011, 1217:77-82.
16. Ritterhouse L.L., Crowe S.R., Niewold T.B., et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis 2011, 70:1569-1574.
17. Ersoy-Evans S. Commentary: vitamin D and autoimmunity: is there an association?. J Am Acad Dermatol 2010, 62:942-944.
18. Cantorna M.T., Mahon B.D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004, 229:1136-1142.
19. Cantorna M.T. Vitamin D and its role in immunology: multiple sclerosis, and inflammatory bowel disease. Prog Biophys Mol Biol 2006, 92:60-64.
20. Kamen D., Aranow C. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol 2008, 20:532-537.
21. Arnson Y., Amital H., Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis 2007, 66:1137-1142.
22. Ratajczak P., Janin A., Peffault de Latour R., et al. Th17/Treg ratio in human graft-versus-host disease. Blood 2010, 116:1165-1171.
23. Prietl B., Pilz S., Wolf M., et al. Vitamin D supplementation and regulatory T cells in apparently healthy subjects: vitamin D treatment for autoimmune diseases?. Isr Med Assoc J 2010, 12:136-139.
24. Royal W., Mia Y., Li H., Naunton K. Peripheral blood regulatory T cell measurements correlate with serum vitamin D levels in patients with multiple sclerosis. J Neuroimmunol 2009, 213:135-141.
25. Adorini L. Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol 2005, 233:115-124.
26. Hsieh C.C., Lin B.F. Dietary factors regulate cytokines in murine models of systemic lupus erythematosus. Autoimmun Rev 2011, 11:22-27.
27. Gregorio J., Meller S., Conrad C., et al. Plasmacytoid dendritic cells sense skin injury and promote wound healing through type I interferons. J Exp Med 2010, 207:2921-2930.
28. Munger K.L., Levin L.I., Hollis B.W., Howard N.S., Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006, 296:2832-2838.
29. Cutolo M., Otsa K., Uprus M., Paolino S., Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun Rev 2007, 7:59-64.
30. Pelajo C.F., Lopez-Benitez J.M., Miller L.C. Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 2010, 9:507-510.
31. Fu L.W., Vender R. Systemic role for vitamin D in the treatment of psoriasis and metabolic syndrome. Dermatol Res Pract 2011, 276079.
32. Motrich R.D., van Etten E., Depovere J., et al. Impact of vitamin D receptor activity on experimental autoimmune prostatitis. J Autoimmun 2009, 32:140-148.
33. Silverberg J.I., Silverberg A.I., Malka E., Silverberg N.B. A pilot study assessing the role of 25 hydroxy vitamin D levels in patients with vitiligo vulgaris. J Am Acad Dermatol 2010, 62:937-941.
34. van Etten E., Branisteanu D.D., Verstuyf A., et al. Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants. Transplantation 2000, 69:1932-1942.
35. Cantorna M.T. Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc 2010, 69:286-289.
36. Stern J.M., Sullivan K.M., Ott S.M., et al. Bone density loss after allogeneic hematopoietic stem cell transplantation: a prospective study. Biol Blood Marrow Transplant 2001, 7:257-264.